Literature DB >> 8046317

Upper airway obstruction in hypothyroidism.

L Pelttari1, E Rauhala, O Polo, M T Hyyppä, E Kronholm, J Viikari, I Kantola.   

Abstract

OBJECTIVES: To determine the occurrence and frequency of nocturnal upper airway obstruction in hypothyroidism.
DESIGN: A case-control study of patients with newly diagnosed hypothyreosis and euthyroid subjects who had been selected from the population register. The subjects underwent sleep recordings with a static-charge-sensitive bed (SCSB).
SETTING: Turku University Hospital and Research and Development Unit, Social Insurance Institution, Turku, Finland.
SUBJECTS: Twenty six consecutive patients underwent sleep recordings with SCSB and a pulse oximeter. One hundred and eighty-eight euthyroid subjects who were previously studied with the SCSB were used as controls. MAIN OUTCOME MEASURES: In a multivariate analysis, hypothyroidism, gender, age, and body mass index (BMI) were considered as predictors for the occurrence of nocturnal breathing abnormalities.
RESULTS: Nocturnal breathing abnormalities were frequent in both groups. Fifty per cent of the hypothyroid patients and 29.3% of the control subjects had at least some episodes of partial or complete upper airway obstruction (P = 0.04). Severe obstruction with episodes of repetitive apnoea was present in 7.7% of the patients and in 1.5% of the controls. The multivariate analysis revealed that the presence of hypothyroidism did not significantly (P = 0.06), and independently of age, BMI or gender, predict nocturnal breathing abnormalities, whereas obesity (P < 0.0001) and male gender (P = 0.0001) were independent and significant predictors.
CONCLUSIONS: The incidence of nocturnal upper airway obstruction is increased in hypothyroidism, but is related to obesity and male gender rather than to hypothyroidism per se.

Entities:  

Mesh:

Year:  1994        PMID: 8046317     DOI: 10.1111/j.1365-2796.1994.tb01280.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS).

Authors:  O Resta; P Carratù; G E Carpagnano; M Maniscalco; G Di Gioia; D Lacedonia; R Giorgino; G De Pergola
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

2.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

3.  Prevalence of Hypothyroidism in a Large Sample of Patients with Obesity Hypoventilation Syndrome.

Authors:  Ahmed S BaHammam; Salih Aleissi; Awad H Olaish; Aljohara S Almeneessier; Anwar A Jammah
Journal:  Nat Sci Sleep       Date:  2020-09-16

4.  Sleep problems and associated comorbidities among adults with Down syndrome.

Authors:  A J Esbensen
Journal:  J Intellect Disabil Res       Date:  2015-11-02

5.  Relationship between sleep apnea and thyroid function.

Authors:  Shoko Takeuchi; Takuro Kitamura; Toyoaki Ohbuchi; Hiroki Koizumi; Risa Takahashi; Nobusuke Hohchi; Hideaki Suzuki
Journal:  Sleep Breath       Date:  2014-03-13       Impact factor: 2.816

Review 6.  The epidemiology of adult obstructive sleep apnea.

Authors:  Naresh M Punjabi
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

7.  Prospective assessment of the risk of obstructive sleep apnea in patients attending a tertiary health facility in Sub-Saharan Africa.

Authors:  Obianuju Beatrice Ozoh; Njideka Ulunma Okubadejo; Ayesha Omolara Akinkugbe; Oluwadamilola Omolara Ojo; Chinyere Nkiru Asoegwu; Casmir Amadi; Ifedayo Odeniyi; Amam Chinyere Mbakwem
Journal:  Pan Afr Med J       Date:  2014-04-21

Review 8.  Neurologic Manifestations of Systemic Disease: Sleep Disorders.

Authors:  Eric M Davis; Chintan Ramani; Mark Quigg
Journal:  Curr Treat Options Neurol       Date:  2020-08-06       Impact factor: 3.972

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.